Amedeo Smart

Free Medical Literature Service

 

Amedeo

Irritable Bowel Syndrome
  Free Subscription

Articles published in
J Gastroenterol Hepatol
    June 2026
  1. ZHU J, Qiu X, Ma R
    Comment on "Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis".
    J Gastroenterol Hepatol. 2026 Jun 7. doi: 10.1111/jgh.70482.
    >> Share

  2. LOH AJC, Loo QY, Ng AK, Khoo XH, et al
    Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
    J Gastroenterol Hepatol. 2026 Jun 3. doi: 10.1111/jgh.70477.
    >> Share

    May 2026
  3. HE Y
    Re-Evaluating Probiotic Efficacy in Irritable Bowel Syndrome: A Call for Rigorous Statistics, Digital Therapeutics, and Microbiome-Driven Precision.
    J Gastroenterol Hepatol. 2026 May 29. doi: 10.1111/jgh.70459.
    >> Share

  4. SUN K, Peng J, Zhu Y
    Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-Constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2026 May 15. doi: 10.1111/jgh.70454.
    >> Share

  5. REN Z, Zhu H
    Comment on "Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis".
    J Gastroenterol Hepatol. 2026 May 14. doi: 10.1111/jgh.70443.
    >> Share

  6. AYAD ME, Yu S, El Shennawy S, Al Mowafy EA, et al
    Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2026 May 8. doi: 10.1111/jgh.70421.
    >> Share

    March 2026
  7. TAO X
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2026 Mar 21. doi: 10.1111/jgh.70363.
    >> Share

  8. TANG ASP, Quek J, Sulaimi F, Sim B, et al
    Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis.
    J Gastroenterol Hepatol. 2026 Mar 12. doi: 10.1111/jgh.70322.
    >> Share

    February 2026
  9. LI X
    Reconsidering Bloating as a Core Endpoint in IBS-C: Commentary on Brenner et al. (2025).
    J Gastroenterol Hepatol. 2026 Feb 26. doi: 10.1111/jgh.70320.
    >> Share

    January 2026
  10. MACK A, Halmos EP, Mogilevski T, Anderson EJ, et al
    A Critical Review of Persistent Gastrointestinal and Extraintestinal Symptoms in Quiescent Inflammatory Bowel Disease: Time for Greater Precision and Clarity.
    J Gastroenterol Hepatol. 2026 Jan 18. doi: 10.1111/jgh.70223.
    >> Share

    December 2025
  11. SIMADIBRATA DM, Koo TH, Utari AP, Ayad M, et al
    Rome III Versus Rome IV Criteria for Diagnosing Irritable Bowel Syndrome in a Southeast Asian Population: Insights From the Rome Foundation Global Epidemiology Study Household Survey.
    J Gastroenterol Hepatol. 2025 Dec 4. doi: 10.1111/jgh.70174.
    >> Share

    November 2025
  12. GHOSHAL UC, Ramakrishna BS, Rathi PM, Shukla A, et al
    Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2025 Nov 18. doi: 10.1111/jgh.70137.
    >> Share

  13. BRENNER DM, Shin AS, Laitman AP, Deutsch JK, et al
    The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint.
    J Gastroenterol Hepatol. 2025 Nov 10. doi: 10.1111/jgh.70119.
    >> Share

  14. YAO YH, Li SN, Yin Q, Liu L, et al
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Nov 3. doi: 10.1111/jgh.70140.
    >> Share

    October 2025
  15. DU Y, Fan H
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Oct 7. doi: 10.1111/jgh.70113.
    >> Share

  16. KARKRA R
    The Association Between Night Shifts and Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Oct 1. doi: 10.1111/jgh.70101.
    >> Share

    September 2025
  17. AHMED A, Chauhan A, Kumari A, Hokari R, et al
    Prevalence of Serologically Defined Celiac Disease in Patients With Irritable Bowel Syndrome in Asia: A Multicountry Hospital-Based Study.
    J Gastroenterol Hepatol. 2025 Sep 13. doi: 10.1111/jgh.70074.
    >> Share

    July 2025
  18. YAN Y, Liu L, Shen XJ
    Comment on "Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome".
    J Gastroenterol Hepatol. 2025 Jul 23. doi: 10.1111/jgh.70032.
    >> Share

  19. YAO Y, You X, Yang S, Xie Y, et al
    Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study.
    J Gastroenterol Hepatol. 2025 Jul 12. doi: 10.1111/jgh.70002.
    >> Share

    March 2025
  20. CHENG L, Wang Q, Wu B, Yan X, et al
    Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16925.
    >> Share

    January 2025
  21. LOO QY, Chuah KH, Hian WX, Khoo XH, et al
    Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1111/jgh.16891.
    >> Share

  22. YU QX, Wang DD, Dong PJ, Zheng LH, et al
    Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Jan 8. doi: 10.1111/jgh.16858.
    >> Share

    December 2024
  23. HISAKI Y, Sawada A, Kobayashi Y, Nishida Y, et al
    Epidemiology of Rome IV Fecal Incontinence in Japan: An Internet Survey of 9995 Individuals.
    J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1111/jgh.16838.
    >> Share

    November 2024
  24. AGGARWAL N, Bhatia U, Dwarakanathan V, Singh AD, et al
    Prevalence and etiologies of non-responsive celiac disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16808.
    >> Share

    August 2024
  25. GONG Q, Xiong F, Zheng Y, Guo Y, et al
    Tea-derived exosome-like nanoparticles prevent irritable bowel syndrome induced by water avoidance stress in rat model.
    J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16714.
    >> Share

    July 2024
  26. WANG J, Sui WN, Zhao YQ, Meng SY, et al
    Genetic evidence for the causal impact of insomnia on gastrointestinal diseases and the mediating effects of adiposity traits.
    J Gastroenterol Hepatol. 2024 Jul 9. doi: 10.1111/jgh.16678.
    >> Share

    May 2024
  27. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
    A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
    >> Share

    January 2024
  28. CHUAH KH, Mahadeva S
    Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?
    J Gastroenterol Hepatol. 2024 Jan 18. doi: 10.1111/jgh.16487.
    >> Share

    November 2023
  29. GHOSHAL UC, Mustafa U, Mukhopadhyay SK
    FODMAP meal challenge test: a novel investigation to predict response to low-FODMAP diet in non-constipating irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Nov 28. doi: 10.1111/jgh.16424.
    >> Share

  30. KWAK N, Lee H, Kim BK, Yu YM, et al
    Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    J Gastroenterol Hepatol. 2023 Nov 13. doi: 10.1111/jgh.16406.
    >> Share

    September 2023
  31. ZLOOF Y, Peretz L, Braun M, Simchoni M, et al
    Hypermobility spectrum disorders and irritable bowel syndrome: A nationwide study of 1.6 million adolescents.
    J Gastroenterol Hepatol. 2023 Sep 2. doi: 10.1111/jgh.16341.
    >> Share

    June 2023
  32. FUTAGAMI S, Kessoku T, Kasai Y, Higurashi T, et al
    Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1111/jgh.16250.
    >> Share

    March 2023
  33. OKUYAMA Y, Matsui D, Ozaki E, Watanabe Y, et al
    Association of low occlusal force as an oral hypofunction with the prevalence of irritable bowel syndrome in Japanese adults.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16175.
    >> Share

  34. KHOO XH, Chong CW, Talha AM, Philip K, et al
    The impact of diet and ethnicity on Gut Microbiota Variation in Irritable Bowel Syndrome: A Multi-centre Study.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16174.
    >> Share

  35. YASUDA R, Arai K, Kudo T, Nambu R, et al
    Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan.
    J Gastroenterol Hepatol. 2023 Mar 6. doi: 10.1111/jgh.16166.
    >> Share

  36. DENG X, Xiao L, Luo M, Xie P, et al
    Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16159.
    >> Share

    December 2022
  37. YANPING W, Gao X, Cheng Y, Liu M, et al
    The Interaction between Obesity and Visceral Hypersensitivity.
    J Gastroenterol Hepatol. 2022 Dec 7. doi: 10.1111/jgh.16083.
    >> Share

    November 2022
  38. GWEE KA, Lee YY, Suzuki H, Ghoshal UC, et al
    Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms.
    J Gastroenterol Hepatol. 2022 Nov 1. doi: 10.1111/jgh.16046.
    >> Share

    August 2022
  39. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    >> Share

    June 2022
  40. ZHANG Y, Fu F, Zhang L, Zhang W, et al
    Telomere is Shortened in Patients with Irritable Bowel Syndrome in the Chinese Population.
    J Gastroenterol Hepatol. 2022 Jun 15. doi: 10.1111/jgh.15912.
    >> Share

    May 2022
  41. BEK S, Teo YN, Tan XH, Fan KH, et al
    Association between Irritable Bowel Syndrome and Micronutrients: A Systematic Review.
    J Gastroenterol Hepatol. 2022 May 17. doi: 10.1111/jgh.15891.
    >> Share

  42. ABUELAZM M, Abdelazeem B
    Vitamin D Supplementation for Irritable Bowel Syndrome: Concerns About the Meta-Analysis.
    J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15883.
    >> Share

  43. UNO Y
    Paradigm shift in FODMAP theory.
    J Gastroenterol Hepatol. 2022;37:954.
    >> Share

    April 2022
  44. CHONG RIH, Yaow CYL, Loh CYL, Teoh SE, et al
    Vitamin D Supplementation for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2022 Apr 8. doi: 10.1111/jgh.15852.
    >> Share

  45. FAN K, Eslick GD, Nair PM, Burns GL, et al
    HUMAN INTESTINAL SPIROCHETOSIS, IRRITABLE BOWEL SYNDROME AND COLONIC POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Gastroenterol Hepatol. 2022 Apr 6. doi: 10.1111/jgh.15851.
    >> Share

    March 2022
  46. ROTH B, Larsson E, Ohlsson B
    Poor intake of vitamins and minerals among patients with irritable bowel syndrome is associated with symptoms.
    J Gastroenterol Hepatol. 2022 Mar 18. doi: 10.1111/jgh.15830.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016